- Home
- Publications
- Publication Search
- Publication Details
Title
Acute myeloid leukemia stem cells and CD33-targeted immunotherapy
Authors
Keywords
-
Journal
BLOOD
Volume 119, Issue 26, Pages 6198-6208
Publisher
American Society of Hematology
Online
2012-01-28
DOI
10.1182/blood-2011-11-325050
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML
- (2012) J. A. Pollard et al. BLOOD
- Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
- (2012) Sylvie Castaigne et al. LANCET
- Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50-70-year old: A phase 1/2 study of the acute leukemia French association
- (2011) Hassan Farhat et al. AMERICAN JOURNAL OF HEMATOLOGY
- DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications
- (2011) H.-A. Hou et al. BLOOD
- Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia
- (2011) Nicolas Goardon et al. CANCER CELL
- Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice
- (2011) George S Vassiliou et al. NATURE GENETICS
- Stem cell gene expression programs influence clinical outcome in human leukemia
- (2011) Kolja Eppert et al. NATURE MEDICINE
- Targeted Drug Delivery by Gemtuzumab Ozogamicin: Mechanism-Based Mathematical Model for Treatment Strategy Improvement and Therapy Individualization
- (2011) Eva Jager et al. PLoS One
- Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?
- (2010) B. Falini et al. BLOOD
- High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicine
- (2010) C. Bachas et al. BLOOD
- Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34- fraction
- (2010) D. C. Taussig et al. BLOOD
- Gemtuzumab ozogamicin for the treatment of acute promyelocytic leukemia: mechanisms of action and resistance, safety and efficacy
- (2010) Massimo Breccia et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial
- (2010) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells
- (2010) R Majeti ONCOGENE
- Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia
- (2009) F. C. Guibal et al. BLOOD
- A robust xenotransplantation model for acute myeloid leukemia
- (2009) P V Sanchez et al. LEUKEMIA
- Analysis of factors that affect in vitro chemosensitivity of leukaemic stem and progenitor cells to gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukaemia
- (2009) M Jawad et al. LEUKEMIA
- Leukemia stem cells
- (2009) Steven W. Lane et al. SEMINARS IN CANCER BIOLOGY
- Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells
- (2008) D. C. Taussig et al. BLOOD
- Stem cell concepts renew cancer research
- (2008) J. E. Dick BLOOD
- Malignant Transformation Initiated by Mll-AF9: Gene Dosage and Critical Target Cells
- (2008) Weili Chen et al. CANCER CELL
- Modeling of C/EBPα Mutant Acute Myeloid Leukemia Reveals a Common Expression Signature of Committed Myeloid Leukemia-Initiating Cells
- (2008) Peggy Kirstetter et al. CANCER CELL
- Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia
- (2008) Roberto Stasi et al. CANCER TREATMENT REVIEWS
- Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin
- (2008) Farhad Ravandi et al. JOURNAL OF CLINICAL ONCOLOGY
- Large interindividual differences in cellular sensitivity to calicheamicin may influence gemtuzumab ozogamicin response in acute myeloid leukemia
- (2008) B F Goemans et al. LEUKEMIA
- Complementing mutations in core binding factor leukemias: from mouse models to clinical applications
- (2008) A M S Müller et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started